NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Sample GSM1492900 Query DataSets for GSM1492900
Status Public on Apr 07, 2015
Title IL-15 7
Sample type genomic
 
Source name Cultured Placenta Villous explant exposed to media supplemented with IL-15
Organism Homo sapiens
Characteristics tissue: Placenta villous explant
trimester: First Trimester
Growth protocol Placental tissues were collected from consenting healthy women undergoing elective pregnancy termination at gestational ages between 7-9 weeks. dNK were isolated from decidua after collagenase and hyaluronidase digestion, depletion of attached cells, and were then enriched by human NK cell enrichment cocktail following the manufacturer’s instructions. The percentage of CD56+/CD16- dNK reached ~87%, CD16+ cells were < 2.1% (Hu et al., 2006). The dNK were trapped inside of hollow fiber (Spectrum Laboratories, Inc., Rancho Dominquez, CA, USA) (HF-dNK) and used for co-culturing with explants in order to eliminate trophoblast cell contamination from dNK when performing EVT DNA extraction. HF permits soluble factors with molecular weight below 500 kDa to be exchanged freely. For each placental specimen, villous explant cultures were set up in 12 well plates on collagen gel. After overnight incubation, explant cultures with EVT outgrowth on villous tips were identified and exposed to medium control (DMEM/F12 supplemented with 10% FBS), or IL-15 alone, or concordant HF-dNK plus IL-15 for a total of 96 hours. 6-8 explants were used for each treatment group in each placental specimen.
Extracted molecule genomic DNA
Extraction protocol For each of the explant cultures, EVT were harvested from collagen gel after dissecting villi tissue and pooled from each treatment group. Previous study has shown that the EVT forming the cell column and migrating on collagen were cytokeratin positive and vimentin negative cells and purity was high (Hu et al., 2006; Hu et al., 2008). Five placental specimens in total were used for global DNA methylation array and Bisulfite pyrosequencing validation. Genomic DNA from EVT was purified using QIAamp DNA mini kit according to the manufacturer’s instructions (Qiagen Inc. Mississauga, ON, Canada).
Label Cy5 and Cy3
Label protocol Cy5 and Cy3
 
Hybridization protocol Illumina HumanMethylation450 BeadChip Protocol
Scan protocol Arrays were imaged using Illumina iScan on a two-color channel
Data processing GenomeStudio 2011.1 software and R version 2.14.0; Normalization using SWAN; The file Unmethylated_and_methylated_signal.txt is available on the series record and contains the raw data.
 
Submission date Aug 28, 2014
Last update date May 17, 2016
Contact name Wendy Robinson
E-mail(s) wprobinsonlab@gmail.com
Organization name University of British Columbia
Department Medical Genetics
Lab Robinosn
Street address 950 W 28th Ave
City Vancouver
State/province BC
ZIP/Postal code V5Z 4H4
Country Canada
 
Platform ID GPL13534
Series (1)
GSE60885 Genome-wide DNA methylation identifies trophoblast invasion-related genes: Claudin-4 and Fucosyltransferase IV control mobility via altering matrix metalloproteinase activity

Data table header descriptions
ID_REF
VALUE Average Beta Values after normalization using SWAN
007B.Detection Pval

Data table
ID_REF VALUE 007B.Detection Pval
cg00000029 0.091314873 0
cg00000108 0.939104692 0
cg00000109 0.882684452 0
cg00000165 0.728469609 0
cg00000236 0.8218907 0
cg00000289 0.644038034 0
cg00000292 0.724660239 0
cg00000321 0.543936299 0
cg00000363 0.362775604 0
cg00000622 0.038866311 0
cg00000658 0.895596762 0
cg00000714 0.165165524 0
cg00000721 0.896949527 0
cg00000734 0.071995217 0
cg00000769 0.081271693 0
cg00000807 0.105645468 0
cg00000884 0.698332918 0
cg00000905 0.116113713 0
cg00000924 0.563425653 0
cg00000948 0.649824023 0

Total number of rows: 466595

Table truncated, full table size 11351 Kbytes.




Supplementary data files not provided
Processed data included within Sample table

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap